Visit AmoyDx at AACR Annual Meeting 2022 in Louisiana, USA
AmoyDx is excited to be back in New Orleans, Louisiana, USA in April for American Association for Cancer Research (AACR) Annual Meeting 2022. Please plan to join us at booth 1265 from 10 - 13 April, 2022 and we look forward to seeing you in New Orleans.
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval of Companion Diagnostic Reagent for the AmoyDx® Pan Lung Cancer PCR Panel
TOKYO and XIAMEN, February 24, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that an application for partial revision of manufacturing and marketing approval for Am
AmoyDx Collaborates with Pierre Fabre to Develop Companion Diagnostics for China Market
Xiamen (China), Castres (France), February 23rd, 2022 – Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE:300685), and the French pharmaceutical group Pierre Fabre announced that the companies have entered into a collaboration to develop Companion Diagnostic (CDx)
AmoyDx Announces Its PLC Panel Adopted as Companion Diagnostic for Brigatinib in Japan
Xiamen, China, January 29, 2022 - Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685), an innovative commercial-stage in vitro diagnostic (IVD) company today announced that the AmoyDx Pan Lung Cancer PCR Panel (the “PLC Panel”) has been adopted by Takeda Ph
AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan
Xiamen and Hong Kong, January 14, 2022 -- Amoy Diagnostics Co., Ltd., (“AmoyDx”) and PREMIA Holdings (HK) Limited (“PREMIA”) today announced the commercial launch of the AmoyDx® Pan Lung Cancer PCR Panel (the “PLC Panel”) in Japan as a reimbursed companio
AmoyDx Distributors Annual Meeting 2021
Xiamen, China, December 10, 2021 - Amoy Diagnostics Co. Ltd. (AmoyDx) Distributors Annual Meeting 2021 was held recently. Over 100 delegates from about 40 countries or regions gathered together virtually.